Page last updated: 2024-11-05

trihexyphenidyl and Classic Galactosemia

trihexyphenidyl has been researched along with Classic Galactosemia in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research Excerpts

ExcerptRelevanceReference
"Classical galactosemia is an autosomal recessive inborn error of metabolism leading to toxic accumulation of galactose and derived metabolites."1.39Movement disorders in adult patients with classical galactosemia. ( Bhatia, KP; Burke, D; Carecchio, M; Chandrashekar, HS; Edwards, MJ; Footitt, EJ; Kojovic, M; Lachmann, RH; Murphy, E; Parees, I; Rubio-Agusti, I, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rubio-Agusti, I1
Carecchio, M1
Bhatia, KP1
Kojovic, M1
Parees, I1
Chandrashekar, HS1
Footitt, EJ1
Burke, D1
Edwards, MJ1
Lachmann, RH1
Murphy, E1

Other Studies

1 other study available for trihexyphenidyl and Classic Galactosemia

ArticleYear
Movement disorders in adult patients with classical galactosemia.
    Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:6

    Topics: Adult; Anti-Dyskinesia Agents; Benzamides; Botulinum Toxins; Brain; Cross-Sectional Studies; Databas

2013